JAMDA
January 7, 2026
Showing 381 - 390 of 8406 results
Policy Snapshot
January 6, 2026
DEA and HHS Extend Telemedicine Controlled-Substance Prescribing Flexibilities Through 2026
The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) have published a temporary rule extending COVID-19 era telemedicine prescribing flexibilities for controlled substances through December 31, 2026. The rule took effect January 1, 2026, and continues the temporar...
JAMDA
January 6, 2026
COVID-19 Vaccination and Impact on Morbidity Among Nursing Home Residents, October 2024–January 2025: An Ecological Analysis
US nursing home residents experience a disproportionate burden of COVID-19–associated cases and hospitalizations. COVID-19 vaccination may reduce the burden in this population; however, data on the association between vaccine uptake and outcomes for this vulnerable population are lacking.
Spotlight
January 6, 2026
2026 Filkin Lecture Features an Inside Look at State Survey Agencies
Amber Clark-Brown, MD, will be giving the much-anticipated Anne-Marie Filkin Lecture at this year’s PALTC26 annual conference in Anaheim, CA. As the only medical director working within a state survey agency (SSA), Dr. Clark-Brown will offer attendees her unique perspective and insights that she’s excited ...
JAMDA
January 5, 2026
Prescription Patterns and Associated Factors of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Use Among Patients Worldwide: A Systematic Review and Meta-Analysis of Real-World Studies
The prescribing patterns of sodium-glucose cotransporter 2 (SGLT2) inhibitors in real-world clinical practice remain inadequately characterized. To address this gap, this meta-analysis aims to synthesize evidence on the prescription trends and clinical factors associated with SGLT2 inhibitor use.
Policy Snapshot
January 5, 2026
CMS Proposed Model Test Would Lower Drug Costs for Medicare Part D
The Centers for Medicare & Medicaid Services (CMS) announced the newly proposed GUARD (Guarding U.S. Medicare Against Rising Drug Costs) Model that would lower the costs of certain prescription drugs covered by Medicare Part D to reflect prices paid in economically comparable countries.
Policy Snapshot
January 5, 2026
CMS Announces $50 Billion in Awards to Strengthen Rural Health in All 50 States
The Centers for Medicare & Medicaid Services (CMS) announced that all 50 states will receive awards under the Rural Health Transformation Program, a $50 billion initiative established under the Working Families Tax Cuts legislation (Public Law 119-21) to strengthen and modernize health care in rural co...
Policy Snapshot
January 5, 2026
2025 QPP Data Submission is Now Open
The Centers for Medicare & Medicaid Services (CMS) has opened data submission for the 2025 performance year of the Quality Payment Program (QPP). Data can be submitted and updated until March 31, 2026, 8:00 PM ET.
Policy Snapshot
January 5, 2026
New CMS LEAD Model Aims to Expand Access to ACOs
The Centers for Medicare & Medicaid Services (CMS) recently announced the Long-term Enhanced ACO Design (LEAD) Model as the Innovation Center’s next Accountable Care Organization (ACO) model, which will focus on reaching more health-care providers who have not joined ACOs, while providing care for pati...
JAMDA
December 31, 2025
Converting Education Into Safer Care in Long-Term Care: Evidence-Based Design, Workforce Reality, and Indonesia's Path
